Showing 341 - 360 results of 487 for search '"Neuroinflammation"', query time: 0.06s Refine Results
  1. 341

    Trimethyltin-Induced Microglial Activation via NADPH Oxidase and MAPKs Pathway in BV-2 Microglial Cells by Da Jung Kim, Yong Sik Kim

    Published 2015-01-01
    “…Trimethyltin (TMT) is known as a potent neurotoxicant that causes neuronal cell death and neuroinflammation, particularly in the hippocampus. Microglial activation is one of the prominent pathological features of TMT neurotoxicity. …”
    Get full text
    Article
  2. 342
  3. 343

    Roles of Brain Angiotensin II in Cognitive Function and Dementia by Masaki Mogi, Jun Iwanami, Masatsugu Horiuchi

    Published 2012-01-01
    “…Moreover, basic experiments suggest a role of brain angiotensin II in neural injury, neuroinflammation, and cognitive function and that RAS blockade attenuates cognitive impairment in rodent dementia models of AD. …”
    Get full text
    Article
  4. 344
  5. 345

    Acute cerebral edema: a lethal neurological complication in a patient with COVID-19 infection. Case report and literature review by M. Puodžiūnaitė, R. Sadeckaitė, A. Čikotienė

    Published 2023-10-01
    “…COVID-19 induces CNS damage through various mechanisms including ACE-2 receptor damage, cytokine storm syndrome, secondary hypoxia, blood-brain barrier disruption, and neuroinflammation. Neurological symptoms correlate with the severity of COVID-19 disease and may range from asymptomatic infection to severe and lethal forms. …”
    Get full text
    Article
  6. 346

    Cognitive disorders: Potential astrocyte-based mechanism by Shiyu Li, Yeru Chen, Gang Chen

    Published 2025-01-01
    “…Dysfunction of astrocytes is intimately linked to cognitive disorders, and we are attempting to understand this phenomenon predominantly from those perspectives: neuroinflammation, astrocytic senescence, connexin, Ca2 + signaling, mitochondrial dysfunction, and the glymphatic system.…”
    Get full text
    Article
  7. 347

    The Effect of Smoking on SIRT3 and Selected Biochemical Variables in Patients with Parkinson’s Disease by Noor Abdulsatar Majeed, Mohammed Bahry Hassin

    Published 2024-10-01
    “…Moreover, biochemical analyzes demonstrated higher levels of oxidative stress markers and pro-inflammatory cytokines in the smoking group, indicating an exacerbation of neuroinflammation and oxidative damage in PD patients who smoke. …”
    Get full text
    Article
  8. 348

    Longitudinal characterization reveals behavioral impairments in aged APP knock in mouse models by Lisa Blackmer-Raynolds, Lyndsey D. Lipson, Isabel Fraccaroli, Ian N. Krout, Jianjun Chang, Timothy Robert Sampson

    Published 2025-02-01
    “…While APPSAA mice have been shown to develop progressive Aβ pathology and neuroinflammation, the age at which behavioral and cognitive impairments begin to develop has yet to be described. …”
    Get full text
    Article
  9. 349

    Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases by Leilei Chen, Qingqing Shen, Yingjuan Liu, Yunqi Zhang, Liping Sun, Xizhen Ma, Ning Song, Junxia Xie

    Published 2025-02-01
    “…However, an imbalance in metal ions, whether excessive or insufficient, is detrimental and can contribute to neuronal death through oxidative stress, ferroptosis, cuproptosis, cell senescence, or neuroinflammation. These processes have been found to be involved in the pathological mechanisms of neurodegenerative diseases. …”
    Get full text
    Article
  10. 350

    Metabolomic and lipidomic pathways in aneurysmal subarachnoid hemorrhage by Bosco Seong Kyu Yang, Spiros L. Blackburn, Philip L. Lorenzi, Huimahn A. Choi, Aaron M. Gusdon

    Published 2025-01-01
    “…They are comprised of a wide variety of subspecies and are critical for cellular energy metabolism, the integrity of the blood-brain barrier, the formation of cell membranes, and intercellular signaling including neuroinflammation and ferroptosis. In this review, metabolomic and lipidomic pathways associated with aSAH are summarized, centering on key metabolites from each metabolomic domain.…”
    Get full text
    Article
  11. 351

    Microbiome immune system interactions in selected neurological disorder by P. Omosigho, G. Sulaiman, O. Okesanya

    Published 2024-07-01
    “…Changes in gut microbiota composition and neuroinflammation mediated by the NLRP3 inflammasome have been observed in AD, suggesting a connection between microbiological variables and the course of the illness. …”
    Get full text
    Article
  12. 352

    Alterations in cerebral perfusion and corresponding brain functional networks in systemic lupus erythematosus with cognitive impairment by Huiyang Liu, Hu Liu, Bailing Tian, Pingting Yang, Guoguang Fan

    Published 2025-01-01
    “…Abstract Cognitive impairment (CI) frequently occurs in patients with systemic lupus erythematosus (SLE) and may result from neuroinflammation processes and neurovascular changes in the brain. …”
    Get full text
    Article
  13. 353

    The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease by Edward C. Lauterbach, Leonardo F. Fontenelle, Antonio L. Teixeira

    Published 2012-01-01
    “…The authors investigated the effects of psychotropics on pathobiological proteins, proteasomal activity, mitochondrial functions, apoptosis, neuroinflammation, trophic factors, stem cells, and neurogenesis. …”
    Get full text
    Article
  14. 354

    Glycogen Synthase Kinase 3β Promotes Postoperative Cognitive Dysfunction by Inducing the M1 Polarization and Migration of Microglia by Jingjin Li, Chonglong Shi, Zhengnian Ding, Wenjie Jin

    Published 2020-01-01
    “…It has been consistently reported that the pathological process of this clinical syndrome is related to neuroinflammation and microglial proliferation. Glycogen synthase kinase 3β (GSK-3β) is a widely expressed kinase with distinct functions in different types of cells. …”
    Get full text
    Article
  15. 355

    Ketamine does not rescue plaque load or gap detection in the 5XFAD mouse model of Alzheimer's disease by Alexa L. Wright, Aldis P. Weible, Olivia B. Estes, Michael Wehr

    Published 2025-02-01
    “…Ketamine has received growing attention for its effects on neuroplasticity and neuroinflammation, and as a treatment for depression and other mental health disorders. …”
    Get full text
    Article
  16. 356

    Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: A literature review by Ubaid Ansari, Jimmy Wen, Burhaan Syed, Dawnica Nadora, Romteen Sedighi, Denise Nadora, Vincent Chen, Forshing Lui

    Published 2024-12-01
    “…This literature review extensively analyzes NP2's role in these conditions, thereby highlighting its contributions to synaptic dysfunction, neuroinflammation, and neurotoxic protein aggregation. …”
    Get full text
    Article
  17. 357

    The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson's Disease by Kemal Ugur Tufekci, Ezgi Civi Bayin, Sermin Genc, Kursad Genc

    Published 2011-01-01
    “…Both mitochondrial dysfunction and neuroinflammation, a common denominator of PD, lead to an increased production of reactive oxygen species, which are detrimental to neurons. …”
    Get full text
    Article
  18. 358

    Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy by Jan M. Keppel Hesselink, Ciro Costagliola, Josiane Fakhry, David J. Kopsky

    Published 2015-01-01
    “…These products are notified in Italy for the nutritional support in glaucoma and neuroinflammation. PEA has been tested in at least 9 double blind placebo controlled studies, among which two studies were in glaucoma, and found to be safe and effective up to 1.8 g/day, with excellent tolerability. …”
    Get full text
    Article
  19. 359

    A Retrospective Cohort Study with Blood Parameters for Early Estimation of Multiple Sclerosis: Ratio Suggestion by Esra Tekin, Sibel Canbaz Kabay, Ayşegül Küçük

    Published 2024-07-01
    “…Conclusion: NLR is considered a neuroinflammation marker. It is argued that NLR reflects systemic inflammation better than neutrophil and lymphocyte counts alone. …”
    Get full text
    Article
  20. 360

    Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives by Byeong-Hyeon Kim, Sujin Kim, Yunkwon Nam, Yong Ho Park, Seong Min Shin, Minho Moon

    Published 2025-01-01
    “…Monoclonal antibodies (MABs) serve as a promising therapeutic approach for AD by selectively targeting key pathogenic factors, such as amyloid-β (Aβ) peptide, tau protein, and neuroinflammation. Specifically, based on their efficacy in removing Aβ plaques from the brains of patients with AD, the U.S. …”
    Get full text
    Article